LIR Life Sciences Corp. (CSE:SKNY)

Canada flag Canada · Delayed Price · Currency is CAD
1.370
+0.180 (15.13%)
At close: Dec 5, 2025
204.44%
Market Cap 25.96M
Revenue n/a
Net Income -412.50K
Shares Out 18.95M
EPS -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 39,337
Average Volume 101,307
Open 1.260
Previous Close 1.190
Day's Range 1.130 - 1.370
52-Week Range 0.450 - 2.000
Beta n/a
RSI 61.04
Earnings Date n/a

About LIR Life Sciences

LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders. The company was incorporated in 2024 and is based in Vancouver, Canada. [Read more]

Industry Pharmaceutical Preparations
Founded 2024
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol SKNY
Full Company Profile

News

There is no news available yet.